Eterna Therapeutics Inc.·4

Jun 23, 8:30 PM ET

Gurrola Sandra M 4

4 · Eterna Therapeutics Inc. · Filed Jun 23, 2023

Insider Transaction Report

Form 4
Period: 2023-06-21
Gurrola Sandra M
VP of Finance
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2023-06-21438874 total
    Common Stock (438 underlying)
  • Exercise/Conversion

    Common Stock

    2023-06-21+4381,107 total
  • Tax Payment

    Common Stock

    2023-06-21$2.48/sh179$444928 total
Footnotes (2)
  • [F1]Each restricted stock unit converts into one share of common stock.
  • [F2]On June 21, 2021, the reporting person was granted 1,750 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.

Documents

1 file
  • 4
    form4.xmlPrimary